3050-6204

NAM Journal

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 112 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact112 DOIs
2

Deposit reference lists for 8 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact8 DOIs
3

Attach ORCID iDs across 7 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 112 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A systematic approach towards long-term, serum-free cultivat… (10.1016/j.namjnl.2025.100008)
Abstract
26.98 11
2 Assessment of the toxic effects of parabens, commonly used p… (10.1016/j.namjnl.2025.100011)
Abstract
26.03 10
3 Complement-ARIE: Catalyzing the development and adoption of… (10.1016/j.namjnl.2025.100026)
Abstract
25.00 9
4 High-resistance coils in E-cigarettes increase heavy metals… (10.1016/j.namjnl.2025.100060)
Abstract
23.86 8
5 Towards replacement of animal experimentation in scientific… (10.1016/j.namjnl.2024.100001)
Abstract References ORCID
22.58 1
6 Highlighting best practices to advance next-generation risk… (10.1016/j.namjnl.2025.100020)
Abstract
22.58 7
7 Unlocking the future of environmental safety: a framework fo… (10.1016/j.namjnl.2025.100028)
Abstract
22.58 7
8 Qualitative and quantitative evaluation of Fetal Bovine Seru… (10.1016/j.namjnl.2025.100047)
Abstract
22.58 7
9 New frontiers in anti-cancer drug testing: The need for a re… (10.1016/j.namjnl.2024.100003)
Abstract
21.13 6
10 A data analysis approach for locomotor behavioral responses… (10.1016/j.namjnl.2025.100033)
Abstract
19.45 5
11 Making NAMs a ‘Complement’ to animal experimentation is the… (10.1016/j.namjnl.2025.100030)
Abstract
17.47 4
12 Sensitivity analysis of the inputs for bioactivity-exposure… (10.1016/j.namjnl.2025.100056)
Abstract
17.47 4
13 A sociological perspective on the challenges of displacing a… (10.1016/j.namjnl.2025.100057)
Abstract
17.47 4
14 A q-RASAR approach for oral and inhalational toxicity predic… (10.1016/j.namjnl.2025.100061)
Abstract
17.47 4
15 Advice for bad toxicologists (10.1016/j.namjnl.2024.100002)
Abstract References
15.05 1
16 Creating training opportunities in new approach methodologie… (10.1016/j.namjnl.2025.100006)
Abstract
15.05 3
17 Acute immobilization assay with Daphnia similis: A miniaturi… (10.1016/j.namjnl.2025.100010)
Abstract
15.05 3
18 Leveraging innovative research tools to meet public health c… (10.1016/j.namjnl.2025.100023)
Abstract
15.05 3
19 Advice for bad computational toxicologists (10.1016/j.namjnl.2025.100024)
Abstract
15.05 3
20 Panel discussions on the global regulatory acceptance and ha… (10.1016/j.namjnl.2025.100027)
Abstract
15.05 3
21 Comparative study of (Q)SAR models for predicting the enviro… (10.1016/j.namjnl.2025.100054)
Abstract
15.05 3
22 A novel in vitro alveolar model (ALIsens®) for hazard assess… (10.1016/j.namjnl.2025.100070)
Abstract
15.05 3
23 NAMazing: The importance of being earnest - a 2025 cross-Atl… (10.1016/j.namjnl.2025.100071)
Abstract
15.05 3
24 Exploring animal methods bias in biomedical research funding… (10.1016/j.namjnl.2024.100004)
Abstract
11.93 2
25 GenoITS: Implementation of an Integrated Testing Strategy wo… (10.1016/j.namjnl.2024.100005)
Abstract
11.93 2
26 AI-driven parametrization of Michaelis–Menten maximal veloci… (10.1016/j.namjnl.2025.100012)
Abstract
11.93 2
27 Balancing chemical safety and animal welfare considerations… (10.1016/j.namjnl.2025.100013)
Abstract
11.93 2
28 Pharmacophore modeling, 2D-QSAR, drug likeness and toxicity… (10.1016/j.namjnl.2025.100019)
Abstract
11.93 2
29 ctxR: Utilities for interacting with the CTX APIs (10.1016/j.namjnl.2025.100031)
Abstract
11.93 2
30 Botulinum neurotoxin: Tracking the transition from lethal do… (10.1016/j.namjnl.2025.100040)
Abstract
11.93 2
31 A survey to evaluate animal methods bias experienced by Indi… (10.1016/j.namjnl.2025.100042)
Abstract
11.93 2
32 New approach methodologies for evaluating developmental and… (10.1016/j.namjnl.2025.100055)
Abstract
11.93 2
33 Determination of acceptable margins of exposure (MoE) for NA… (10.1016/j.namjnl.2025.100062)
Abstract
11.93 2
34 Transitional initiatives for advancing the phasing out of th… (10.1016/j.namjnl.2025.100065)
Abstract
11.93 2
35 Managing change while phasing out animal testing in chemical… (10.1016/j.namjnl.2026.100079)
Abstract
11.93 2
36 Using Caenorhabditis elegans and zebrafish embryos (Danio re… (10.1016/j.namjnl.2026.100080)
Abstract
11.93 2
37 A miniaturised method for feeding rate in daphnids–A physiol… (10.1016/j.namjnl.2025.100009)
Abstract
7.53 1
38 Next-generation risk assessment: Integrating in vitro data a… (10.1016/j.namjnl.2025.100018)
Abstract
7.53 1
39 Development of a tool for measuring uncertainty of acute cyt… (10.1016/j.namjnl.2025.100021)
Abstract
7.53 1
40 NAMazing: Déjà Vu at the lab bench - Why animal-free science… (10.1016/j.namjnl.2025.100022)
Abstract
7.53 1
41 Development and characterization of a standardized adipogene… (10.1016/j.namjnl.2025.100029)
Abstract
7.53 1
42 Including genetic susceptibility towards Parkinson’s disease… (10.1016/j.namjnl.2025.100036)
Abstract
7.53 1
43 A cryopreserved and in vivo-in vitro validated human induced… (10.1016/j.namjnl.2025.100039)
Abstract
7.53 1
44 Exploring the Mechanisms of EDCs-Induced Metabolic Disorders… (10.1016/j.namjnl.2025.100041)
Abstract
7.53 1
45 TOXTRUST: a tool leveraging the Dempster-Shafer Theory for r… (10.1016/j.namjnl.2025.100043)
Abstract
7.53 1
46 HepaRG™ cell micronucleus assay as a genetic toxicology new… (10.1016/j.namjnl.2025.100045)
Abstract
7.53 1
47 Decoding cellular stress states for toxicology using single-… (10.1016/j.namjnl.2025.100046)
Abstract
7.53 1
48 Gaining confidence in in vitro toxicity data with measured e… (10.1016/j.namjnl.2025.100048)
Abstract
7.53 1
49 Pursuing societal impact in research projects on NAM develop… (10.1016/j.namjnl.2025.100050)
Abstract
7.53 1
50 Next-generation non-animal models for inflammatory bowel dis… (10.1016/j.namjnl.2025.100051)
Abstract
7.53 1